File(s) under permanent embargo
Should antidiabetic medicines be considered to reduce cardiometabolic risk in patients with serious mental illness?
Version 3 2024-06-19, 15:58
Version 2 2024-06-02, 14:46
Version 1 2023-02-08, 03:42
journal contribution
posted on 2024-06-19, 15:58 authored by Kevin Mc NamaraKevin Mc Namara, H Alzubaidi, M Murray, C Samorinha, James DunbarJames Dunbar, Vincent VersaceVincent Versace, D CastleShould antidiabetic medicines be considered to reduce cardiometabolic risk in patients with serious mental illness?
History
Journal
Medical Journal of AustraliaVolume
217Pagination
S29-S33Location
AustraliaPublisher DOI
ISSN
0025-729XeISSN
1326-5377Language
EnglishPublication classification
C1 Refereed article in a scholarly journalIssue
S7Publisher
WILEYUsage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineMedicine, General & InternalGeneral & Internal MedicineMetabolic diseasesDiabetes mellitustype 2LipidsObesityAdverse drug reactionsCardiovascular agentsReview articleINDUCED WEIGHT-GAINPLACEBO-CONTROLLED TRIALLIFE-STYLE INTERVENTIONDOUBLE-BLINDMETFORMINPREVENTIONSCHIZOPHRENIAOLANZAPINEBEHAVIORSOBESITYFaculty of HealthSchool of Medicine111799 Public Health and Health Services not elsewhere classified920499 Public Health (excl. Specific Population Health) not elsewhere classified420699 Public health not elsewhere classified200499 Public health (excl. specific population health) not elsewhere classified
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC